Documents - PR EU, Brussels
86 documents of PR EU, Brussels
Sort by: Date / Relevance
Non-paper on online disinformation: the need for more transparency
By means of this non-paper, the Netherlands intends to outline its contribution on possible next steps to address the spread of ...
Non-paper - Future of Crisis Management in EU context
Non-paper on the future of EU crisis management by the Netherlands, Sweden and Romania.
Non-paper on the Digital Services Act package and the short-term holiday rental of residential spaces
Dutch non-paper on the Digital Services Act package and the short-term holiday rental of residential spaces.
Non-paper Promoting Gender Equality Through Trade Policy
Belgium, Denmark, Spain, Finland, France, Ireland, Italy, Luxembourg, the Netherlands, and Sweden believe the EU can continue to ...
Considerations of France and the Netherlands regarding intervention on platforms with a gatekeeper position
This discussion document elaborates on the issue of intervention on “large digital platforms with significant network effects ...
Joint Statement on the increase of the EU’s 2030 Climate Target
Joint Statement on the increase of the EU’s 2030 Climate Target supported by Denmark, Estonia, Finland, France, Ireland, Latvia, ...
Non-paper - Innovative and trustworthy AI: two sides of the same coin
Position paper on behalf of Denmark, Belgium, the Czech Republic, Finland, France, Estonia, Ireland, Latvia, Luxembourg, the ...
Non-paper on the 2020 update of the EU Digital Education Action Plan
This non-paper is the government's response to the public consultation launched by the European Commission on the new Digital ...
Safe chemicals for our common future
In a joint Op-ed, Environment Ministers of ten European countries call on the Commission to develop an ambitious long-term ...
The Netherlands: Key messages to the European Commission in response to the public consultation on Pharmaceuticals – safe and affordable medicines (new EU Pharmaceutical Strategy)
The Netherlands takes the opportunity to respond to the open consultation of the European Commission on the Pharmaceutical ...